Medicine: Common antibiotic found useful in accelerating recovery in tuberculosis patients
Singapore, June 21, 2021.- Globally, an estimated 10 million people develop tuberculosis (TB) each year and the disease remains a leading cause of death from a single infectious agent. Standard short-course anti-TB treatment still requires a regimen of at least six months of antimicrobial drugs, and drug-resistant TB is anContinuar Leyendo


















